Neelam, S., Mellon, J., Wilkerson, A., & Niederkorn, J. Y. (2019). Defective FasL expression is associated with increased resistance to melanoma liver metastases and enhanced natural kill cell activity. Melanoma Res.
Chicago ZitierstilNeelam, Sudha, Jessamee Mellon, Amber Wilkerson, und Jerry Y. Niederkorn. "Defective FasL Expression Is Associated With Increased Resistance to Melanoma Liver Metastases and Enhanced Natural Kill Cell Activity." Melanoma Res 2019.
MLA ZitierstilNeelam, Sudha, Jessamee Mellon, Amber Wilkerson, und Jerry Y. Niederkorn. "Defective FasL Expression Is Associated With Increased Resistance to Melanoma Liver Metastases and Enhanced Natural Kill Cell Activity." Melanoma Res 2019.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.